BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19383288)

  • 1. Mice thrive without Cdk4 and Cdk2.
    Barrière C; Santamaría D; Cerqueira A; Galán J; Martín A; Ortega S; Malumbres M; Dubus P; Barbacid M
    Mol Oncol; 2007 Jun; 1(1):72-83. PubMed ID: 19383288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53.
    Padmakumar VC; Aleem E; Berthet C; Hilton MB; Kaldis P
    Mol Cell Biol; 2009 May; 29(10):2582-93. PubMed ID: 19307310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.
    Kang J; Sergio CM; Sutherland RL; Musgrove EA
    BMC Cancer; 2014 Jan; 14():32. PubMed ID: 24444383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point.
    Bisteau X; Paternot S; Colleoni B; Ecker K; Coulonval K; De Groote P; Declercq W; Hengst L; Roger PP
    PLoS Genet; 2013 May; 9(5):e1003546. PubMed ID: 23737759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2.
    Gillam MP; Nimbalkar D; Sun L; Christov K; Ray D; Kaldis P; Liu X; Kiyokawa H
    Oncogene; 2015 Feb; 34(7):932-8. PubMed ID: 24531709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cdk7-Cdk4 T-loop phosphorylation cascade promotes G1 progression.
    Schachter MM; Merrick KA; Larochelle S; Hirschi A; Zhang C; Shokat KM; Rubin SM; Fisher RP
    Mol Cell; 2013 Apr; 50(2):250-60. PubMed ID: 23622515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoiesis specific loss of Cdk2 and Cdk4 results in increased erythrocyte size and delayed platelet recovery following stress.
    Jayapal SR; Wang CQ; Bisteau X; Caldez MJ; Lim S; Tergaonkar V; Osato M; Kaldis P
    Haematologica; 2015 Apr; 100(4):431-8. PubMed ID: 25616574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
    Upton JW; van Dyk LF; Speck SH
    Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rb/Cdk2/Cdk4 triple mutant mice elicit an alternative mechanism for regulation of the G1/S transition.
    Li W; Kotoshiba S; Berthet C; Hilton MB; Kaldis P
    Proc Natl Acad Sci U S A; 2009 Jan; 106(2):486-91. PubMed ID: 19129496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdk2 and Cdk4 regulate the centrosome cycle and are critical mediators of centrosome amplification in p53-null cells.
    Adon AM; Zeng X; Harrison MK; Sannem S; Kiyokawa H; Kaldis P; Saavedra HI
    Mol Cell Biol; 2010 Feb; 30(3):694-710. PubMed ID: 19933848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2.
    Pack LR; Daigh LH; Chung M; Meyer T
    Nat Commun; 2021 Jun; 12(1):3356. PubMed ID: 34099663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdk1, but not Cdk2, is the sole Cdk that is essential and sufficient to drive resumption of meiosis in mouse oocytes.
    Adhikari D; Zheng W; Shen Y; Gorre N; Ning Y; Halet G; Kaldis P; Liu K
    Hum Mol Genet; 2012 Jun; 21(11):2476-84. PubMed ID: 22367880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
    J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
    Keenan SM; Lents NH; Baldassare JJ
    J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A confederacy of kinases: Cdk2 and Cdk4 conspire to control embryonic cell proliferation.
    Hinds PW
    Mol Cell; 2006 May; 22(4):432-3. PubMed ID: 16713571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-phase lengthening induced by p16(INK4a) overexpression in malignant cells with wild-type pRb and p53.
    Chien WW; Domenech C; Catallo R; Salles G; Ffrench M
    Cell Cycle; 2010 Aug; 9(16):3286-96. PubMed ID: 20703084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress-mediated exit to quiescence restricted by increasing persistence in CDK4/6 activation.
    Yang HW; Cappell SD; Jaimovich A; Liu C; Chung M; Daigh LH; Pack LR; Fan Y; Regot S; Covert M; Meyer T
    Elife; 2020 Apr; 9():. PubMed ID: 32255427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6.
    Malumbres M; Sotillo R; Santamaría D; Galán J; Cerezo A; Ortega S; Dubus P; Barbacid M
    Cell; 2004 Aug; 118(4):493-504. PubMed ID: 15315761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation.
    Berthet C; Klarmann KD; Hilton MB; Suh HC; Keller JR; Kiyokawa H; Kaldis P
    Dev Cell; 2006 May; 10(5):563-73. PubMed ID: 16678773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.